Ajay K Gopal Selected Research

Myelodysplastic Syndromes (Myelodysplastic Syndrome)

11/2023	Targeted Radiation Delivery Before Haploidentical HCT for High-risk Leukemia or MDS Patients Yields Long-Term Survivors.
1/2019	Outcomes of Patients With Therapy-Related MDS After Chemoimmunotherapy for Chronic Lymphocytic Leukemia Compared With Patients With De Novo MDS: A Single-Institution Experience.
9/2014	Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndrome.
12/2009	Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ajay K Gopal Research Topics

Disease

54	Lymphoma (Lymphomas) 05/2024 - 05/2002
51	Neoplasms (Cancer) 05/2024 - 05/2002
36	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 10/2003
24	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023 - 05/2004
19	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 05/2024 - 10/2003
19	Hodgkin Disease (Hodgkin's Disease) 01/2023 - 09/2008
19	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020 - 05/2002
15	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 10/2023 - 08/2014
13	Hematologic Neoplasms (Hematological Malignancy) 12/2021 - 05/2005
9	Multiple Myeloma 02/2022 - 02/2014
8	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2021 - 02/2014
8	Leukemia 12/2020 - 02/2008
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2020 - 03/2006
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2023 - 12/2009
4	Thrombocytopenia (Thrombopenia) 12/2022 - 01/2015
4	Myeloid Leukemia (Leukemia, Myelocytic) 12/2020 - 05/2007
4	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 11/2017 - 07/2009
4	Residual Neoplasm 02/2016 - 11/2010
3	Neutropenia 12/2022 - 03/2014
3	Fatigue 01/2020 - 01/2015
3	Disease Progression 01/2016 - 06/2008
2	Hypertension (High Blood Pressure) 02/2024 - 01/2017
2	Diarrhea 12/2021 - 03/2014
2	AIDS-Related Complex (ARC) 01/2021 - 12/2019
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 01/2016
2	Hemorrhage 01/2019 - 05/2017
2	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2017 - 01/2015
2	Pathologic Complete Response 02/2016 - 02/2015

Drug/Important Bio-Agent (IBA)

26	Rituximab (Mabthera)FDA Link 05/2024 - 05/2004
17	Brentuximab VedotinIBA 08/2021 - 06/2012
12	Etoposide (VP 16)FDA LinkGeneric 01/2023 - 05/2002
12	procaine isothiocyanate (PRIT)IBA 12/2020 - 06/2007
12	Monoclonal AntibodiesIBA 01/2020 - 05/2002
11	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023 - 05/2002
9	Chimeric Antigen ReceptorsIBA 05/2024 - 09/2008
9	Proteins (Proteins, Gene)FDA Link 02/2022 - 11/2010
8	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 01/2017
8	Radioisotopes (Radionuclides)IBA 01/2021 - 11/2010
8	fludarabineIBA 01/2021 - 12/2009
7	Biotin (Vitamin H)FDA Link 01/2018 - 06/2007
7	StreptavidinIBA 11/2016 - 02/2008
7	Immunoconjugates (Immunoconjugate)IBA 01/2016 - 06/2007
6	Prednisone (Sone)FDA LinkGeneric 01/2023 - 01/2017
6	Dexamethasone (Maxidex)FDA LinkGeneric 12/2022 - 04/2009
6	idelalisibIBA 12/2021 - 03/2014
6	AntibodiesIBA 08/2014 - 06/2007
5	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 01/2017
5	axicabtagene ciloleucelIBA 12/2022 - 01/2018
4	ibrutinibIBA 02/2024 - 10/2018
4	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2020
4	Immune Checkpoint InhibitorsIBA 10/2023 - 12/2021
4	Bortezomib (Velcade)FDA Link 02/2022 - 10/2015
4	Carboplatin (JM8)FDA LinkGeneric 08/2021 - 08/2010
4	Bendamustine Hydrochloride FDA Link 01/2021 - 12/2014
4	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2021 - 10/2008
4	DOTA-biotin (90Y-DOTA-biotin)IBA 12/2020 - 05/2009
4	AntigensIBA 12/2019 - 06/2007
4	tositumomab I-131 (Bexxar)FDA Link 01/2016 - 05/2008
3	Lenalidomide (CC 5013)FDA Link 05/2024 - 01/2021
3	Agammaglobulinaemia Tyrosine KinaseIBA 02/2024 - 10/2018
3	Iodine-131IBA 11/2023 - 09/2014
3	Proteasome InhibitorsIBA 02/2022 - 10/2015
3	utomilumabIBA 01/2022 - 01/2018
3	IceIBA 08/2021 - 04/2013
3	Melphalan (Alkeran)FDA LinkGeneric 01/2021 - 10/2008
3	FenretinideIBA 01/2017 - 05/2004
3	TRU 016IBA 01/2015 - 02/2014
3	HLA-DR Antigens (HLA-DR)IBA 05/2009 - 06/2007
2	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2023 - 10/2008
2	pembrolizumabIBA 01/2023 - 01/2020
2	polatuzumab vedotinIBA 01/2023 - 01/2021
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2022 - 12/2013
2	CreatinineIBA 02/2022 - 05/2017
2	LigandsIBA 01/2022 - 05/2007
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2021 - 08/2021
2	Ifosfamide FDA LinkGeneric 08/2021 - 11/2018
2	Carmustine (FIVB)FDA Link 01/2021 - 10/2008
2	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 04/2009
2	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 01/2017
2	Astatine-211IBA 10/2019 - 03/2015
2	Sirolimus (Rapamycin)FDA Link 01/2019 - 01/2018
2	Transaminases (Aminotransferases)IBA 01/2018 - 03/2014
2	Alkylating AgentsIBA 01/2017 - 03/2014
2	RetinoidsIBA 01/2017 - 10/2015
2	Phosphotransferases (Kinase)IBA 01/2016 - 10/2015
2	ibritumomab tiuxetan (Zevalin)FDA Link 02/2015 - 07/2011

Therapy/Procedure

55	Therapeutics 05/2024 - 05/2002
32	Radioimmunotherapy 01/2024 - 05/2002
24	Cell Transplantation 11/2023 - 05/2005
23	Drug Therapy (Chemotherapy) 02/2024 - 04/2008
18	Stem Cell Transplantation 08/2021 - 05/2002
10	Transplantation 01/2023 - 05/2002
8	Homologous Transplantation 11/2022 - 07/2006
5	Radiotherapy 01/2020 - 05/2009
5	Hematopoietic Stem Cell Transplantation 05/2013 - 10/2003
4	Immunotherapy 01/2023 - 01/2016
4	Autologous Transplantation 01/2020 - 07/2006
2	Aftercare (After-Treatment) 12/2022 - 01/2018
2	Injections 02/2022 - 12/2020
2	Induction Chemotherapy 02/2016 - 06/2008